| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 2,405,000 | 2,485,000 | 2,093,000 | 3,091,000 | | Cost of Revenue | 1,743,000 | 1,900,000 | 1,669,000 | 2,332,000 | | | Gross Profit | 662,000 | 585,000 | 424,000 | 759,000 | | | Operating Expenses | | Research Development | 99,000 | 142,000 | 140,000 | 137,000 | | Selling General and Administrative | 360,000 | 435,000 | 385,000 | 409,000 | | Non Recurring | 56,000 | (20,000) | (10,000) | 63,000 | | Others |
-
|
-
|
-
| 33,000 | | | | Total Operating Expenses |
-
|
-
|
-
| 642,000 | | | | Operating Income or Loss | 147,000 | 28,000 | (91,000) | 117,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | (15,000) | 45,000 | 12,000 | | Earnings Before Interest And Taxes | 155,000 | 13,000 | (46,000) | 129,000 | | Interest Expense | 26,000 | 26,000 | 28,000 | 29,000 | | Income Before Tax | 129,000 | (13,000) | (74,000) | 100,000 | | Income Tax Expense | 28,000 | (213,000) | 40,000 | 13,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 101,000 | 200,000 | (114,000) | 87,000 | | | Non-recurring Events | | Discontinued Operations | (5,000) | 295,000 | (1,000) | 128,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 96,000 | 495,000 | (115,000) | 215,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $96,000 | $495,000 | ($115,000) | $215,000 |
|
3.31% Nasdaq 
Income Statement
